Imatinib Enhances Functional Outcome after Spinal Cord Injury

Open Access

Peer-reviewed

Research Article

Mathew B. Abrams ,

* E-mail: mathew.abrams@ki.se

Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
⨯
Ingrid Nilsson,

Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
⨯
Sebastian A. Lewandowski,

Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
⨯
Jacob Kjell,

Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
⨯
Simone Codeluppi,

Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
⨯
Lars Olson,

Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
⨯
Ulf Eriksson

Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
⨯

Reader Comments (0)

Spinal cord injury
Is the Subject Area "Spinal cord injury" applicable to this article?

Thanks for your feedback.
Spinal cord
Is the Subject Area "Spinal cord" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Bladder
Is the Subject Area "Bladder" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Astrocytes
Is the Subject Area "Astrocytes" applicable to this article?

Thanks for your feedback.